Grove Collaborative’s Strategic Shift for Profitability
Grove Collaborative reports Q2 2024 results, focusing on profitability, customer experience improvements, and transition to Shopify.
- Latest
- Trending
Grove Collaborative reports Q2 2024 results, focusing on profitability, customer experience improvements, and transition to Shopify.
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Microvast reports record Q2 2024 revenue at $83.7M, up 12%. Gross margin hits 32.5% amid EMEA sales boost, despite challenges.
Bruker sees strong growth in Q2 2024, with strategic acquisitions boosting revenues despite challenges in biopharma and Chinese markets.
Honest Company aims for mid to high-single digit growth, expanding in Walmart and enhancing e-commerce with new product launches.
Insulet's stock fell 8.8% despite raised revenue guidance, amid concerns over slowing user growth.
RE/MAX Holdings sees international growth and launches new tech, despite North American challenges in Q2 2024.
WSFS Financial's strong ratings affirmed by KBRA, highlighting stability in earnings, liquidity, and diversified income.
Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
Sweetgreen soars on strong earnings, while Intel drops. Akamai leads the S&P 500 on robust demand.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.